研究用フローサイトと理化学分析

世界のリサーチ分野のお客さまへ先端の検査装置のご案内です。

お問い合わせはこちら

sysmex

研究用フローサイトと理化学分析sysmex

CyFlow CD79a Purified

品番 AA059748
抗体名 Anti-H/M/R CD79A PURI,HM57
包装単位 0.1 mg
濃度 1 mg/ml
容量 0.1 ml
関連製品
(アイソタイプコントロール)
Mouse IgG1 Purified (BJ561896)
Mouse IgG1 Purified (AS224818)
反応性|交差吸着 Human | Mouse | Rat | Pig | Cow | Horse | Rabbit | Guinea pig | Opossum | Chicken レーザー
抗原 CD79a, IgA, MB-1, MB1 最大蛍光波長 -
クローン HM57 最大励起波長 -
ホスト Mouse 標識/Format Purified
アイソタイプ IgG1 研究分野 Immunophenotyping
クローナリティ monoclonal 用途

Flow cytometry
Immunohistochemistry

Anti-H/M/R CD79A PURI,HM57

特異性

The mouse monoclonal antibody HM57 recognizes CD79a, a 40-45 kDa subunit of B cell antigen-specific receptor (BCR) and its early developmental forms.

抗原情報

CD79a (Ig α, MB1) forms disulfide-linked heterodimer with CD79b (Ig β, B29). They both are transmembrane proteins with extended cytoplasmic domains containing immunoreceptor tyrosine activation motives (ITAMs), and together with cell surface immunoglobulin they constitute B-cell antigen-specific receptor (BCR). CD79a and b are the first components of BCR that are expressed developmentally. They appear on pro-B cells in association with the endoplasmic reticulum chaperone calnexin. Subsequently, in pre-B cells, CD79 heterodimer is associated with λ5-VpreB surrogate immunoglobulin and later with antigen-specific surface immunoglobulins. At the plasma cell stage, CD79a is present as an intracellular component. CD79a/b complex interacts with Src-family tyrosine kinase Lyn, which phosphorylates its cytoplasmic ITAM motives to form docking sites for downstream signaling.

利用方法

保存方法

Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.

安定性情報

Do not use after expiration date stamped on vial label.

レファレンス

• Bannish G, Fuentes-Pananá EM, Cambier JC, Pear WS, Monroe JG: Ligand‑independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J·Exp·Med. 2001·Dec·3; 194(11):1583‑96. <·PMID:·11733573·>
• Doussis IA, Gatter KC, Mason DY: CD68 reactivity of non‑macrophage derived tumours in cytological specimens. J·Clin·Pathol. 1993·Apr; 46(4):334‑6. <·PMID:·7684403·>
• Faldyna M, Samankova P, Leva L, Cerny J, Oujezdska J, Rehakova Z, Sinkora J: Cross‑reactive anti‑human monoclonal antibodies as a tool for B‑cell identification in dogs and pigs. Vet·Immunol·Immunopathol. 2007·Sep·15; 119(1‑2):56‑62. <·PMID:·17673300·>
• Fuentes-Pananá EM, Bannish G, Karnell FG, Treml JF, Monroe JG: Analysis of the individual contributions of Igalpha (CD79a)‑ and Igbeta (CD79b)‑mediated tonic signaling for bone marrow B cell development and peripheral B cell maturation. J·Immunol. 2006·Dec·1; 177(11):7913‑22. <·PMID:·17114463·>
• Fuentes-Pananá EM, Bannish G, Shah N, Monroe JG: Basal Igalpha/Igbeta signals trigger the coordinated initiation of pre‑B cell antigen receptor‑dependent processes. J·Immunol. 2004·Jul·15; 173(2):1000‑11. <·PMID:·15240688·>
• Fuentes-Pananá EM, Bannish G, van der Voort D, King LB, Monroe JG: Ig alpha/Ig beta complexes generate signals for B cell development independent of selective plasma membrane compartmentalization. J·Immunol. 2005·Feb·1; 174(3):1245‑52. <·PMID:·15661879·>
• Jones M, Cordell JL, Beyers AD, Tse AG, Mason DY: Detection of T and B cells in many animal species using cross‑reactive anti‑peptide antibodies. J·Immunol. 1993·Jun·15; 150(12):5429‑35. <·PMID:·8515069·>
• Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, Jaffe E, Ralfkiaer E, Dallenbach F, Stein H, et al.: CD79a: a novel marker for B‑cell neoplasms in routinely processed tissue samples. Blood. 1995·Aug·15; 86(4):1453‑9. <·PMID:·7632952·>
• Mason DY, Cordell JL, Tse AG, van Dongen JJ, van Noesel CJ, Micklem K, Pulford KA, Valensi F, Comans-Bitter WM, Borst J, et al: The IgM‑associated protein mb‑1 as a marker of normal and neoplastic B cells. J·Immunol. 1991·Dec·1; 147(11):2474‑82. <·PMID:·1747162·>
• Mason DY, van Noesel CJ, Cordell JL, Comans-Bitter WM, Micklem K, Tse AG, van Lier RA, van Dongen JJ: The B29 and mb‑1 polypeptides are differentially expressed during human B cell differentiation. Eur·J·Immunol. 1992·Oct; 22(10):2753‑6. <·PMID:·1396979·>
• Pike KA, Iacampo S, Friedmann JE, Ratcliffe MJ: The cytoplasmic domain of Ig alpha is necessary and sufficient to support efficient early B cell development. J·Immunol. 2004·Feb·15; 172(4):2210‑8. <·PMID:·14764688·>
• van Noesel CJ, van Lier RA, Cordell JL, Tse AG, van Schijndel GM, de Vries EF, Mason DY, Borst J: The membrane IgM‑associated heterodimer on human B cells is a newly defined B cell antigen that contains the protein product of the mb‑1 gene. J·Immunol. 1991·Jun·1; 146(11):3881‑8. <·PMID:·2033258·>
• Kishimoto T, Goyert S, Kikutani H, Mason D, Miyasaka M, Moretta L, Ohno T, Okumura K, Shaw S, Springer TA, Sugamura K, Sugawara H, von dem Borne AEGK, Zola H (Eds): Leucocyte Typing VI. Garland·Publishing·Inc,·New·York. 1997; 1‑1342. <·NLM·ID:·9712219·>

Available Safety Data Sheets

CyFlow™ monoclonal antibodies SDS CA EN

Available Technical Data Sheets

CyFlow™ CD79a Purified (HM57) AA059748 TDS (US)